The increasing demand for genetic cancer risk assessment (GCRA) services has been fueled by the rapid evolution of genetic information and direct-to-consumer marketing by commercial genetic testing vendors. Identifying hereditary cancer predisposition through genetic cancer risk assessment (GCRA) allows for intensified measures to prevent cancers or detect them at an earlier, more treatable stage. Once delivered primarily through academic health centers, the demand for GCRA services in the community setting is steadily increasing.  There is a surge in demand for GCRA services across the nation, but too few clinicians with adequate training to provide GCRA services.